Role of inflammatory and hemostatic biomarkers in Alzheimer’s and vascular dementia – A pilot study from a tertiary center in Northern India
- 1 October 2017
- journal article
- Published by Elsevier in Asian Journal of Psychiatry
- Vol. 29, 59-62
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- The Role of Peripheral Inflammatory Markers in Dementia and Alzheimer's Disease: A Meta-AnalysisThe Journals of Gerontology, Series A: Biological Sciences and Medical Sciences, 2012
- A Meta-Analysis of Cytokines in Alzheimer's DiseaseBiological Psychiatry, 2010
- Is Sticky Blood Bad for the Brain?Arteriosclerosis, Thrombosis, and Vascular Biology, 2010
- Activation of Hemostasis and Decline in Cognitive Function in Older PeopleArteriosclerosis, Thrombosis, and Vascular Biology, 2010
- Elevated plasma fibrin D‐dimer as a risk factor for vascular dementia: the Three‐City cohort studyJournal of Thrombosis and Haemostasis, 2009
- Blood inflammatory markers and risk of dementia: The Conselice Study of Brain AgingNeurobiology of Aging, 2007
- Cognitive Decline and Markers of Inflammation and Hemostasis: The Edinburgh Artery StudyJournal of the American Geriatrics Society, 2007
- Dementia in subjects with atrial fibrillation: hemostatic function and the role of anticoagulationJournal of Thrombosis and Haemostasis, 2004
- Increased plasma levels of interleukin-1, interleukin-6 and α-1-antichymotrypsin in patients with Alzheimer's disease: peripheral inflammation or signals from the brain?Journal of Neuroimmunology, 2000
- Serum interleukin-6 and interleukin-6 soluble receptor in Alzheimer's diseaseNeuroscience Letters, 1998